7432-s and Genital-Diseases--Female

7432-s has been researched along with Genital-Diseases--Female* in 2 studies

Other Studies

2 other study(ies) available for 7432-s and Genital-Diseases--Female

Article	Year
[Treatment of obstetric and gynecologic diseases with anti-inflammatory drug cedax]. Akusherstvo i ginekologiia, 2002, Volume: 41 Suppl 1 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Ceftibuten; Cephalosporins; Female; Genital Diseases, Female; Humans; Kidney Diseases; Middle Aged; Pregnancy; Pregnancy Complications	2002
[Clinical studies of ceftibuten in the field of obstetrics and gynecology]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:1 Clinical studies on ceftibuten (CETB, 7432-S) were carried out in the field of obstetrics and gynecology. A total of 6 patients comprising 1 case of endometritis, 3 of bartholin's abscess, 1 of adnexitis and 1 of vulvar abscess was given 200-300 mg of CETB divided into 2 or 3 equal oral doses daily for 5 days. The clinical efficacy rate was 83 percent. Neither adverse reactions nor abnormal laboratory values were observed in any of the cases. From the results, it was concluded that CETB was an useful antibiotic in the field of obstetrics and gynecology. Topics: Administration, Oral; Adult; Capsules; Ceftibuten; Cephalosporins; Endometritis; Female; Genital Diseases, Female; Humans; Middle Aged; Pelvic Inflammatory Disease	1990

Article

Year

[Treatment of obstetric and gynecologic diseases with anti-inflammatory drug cedax].

Akusherstvo i ginekologiia, 2002, Volume: 41 Suppl 1

Topics: Adolescent; Adult; Anti-Inflammatory Agents; Ceftibuten; Cephalosporins; Female; Genital Diseases, Female; Humans; Kidney Diseases; Middle Aged; Pregnancy; Pregnancy Complications

2002

[Clinical studies of ceftibuten in the field of obstetrics and gynecology].

The Japanese journal of antibiotics, 1990, Volume: 43, Issue:1

Clinical studies on ceftibuten (CETB, 7432-S) were carried out in the field of obstetrics and gynecology. A total of 6 patients comprising 1 case of endometritis, 3 of bartholin's abscess, 1 of adnexitis and 1 of vulvar abscess was given 200-300 mg of CETB divided into 2 or 3 equal oral doses daily for 5 days. The clinical efficacy rate was 83 percent. Neither adverse reactions nor abnormal laboratory values were observed in any of the cases. From the results, it was concluded that CETB was an useful antibiotic in the field of obstetrics and gynecology.

Topics: Administration, Oral; Adult; Capsules; Ceftibuten; Cephalosporins; Endometritis; Female; Genital Diseases, Female; Humans; Middle Aged; Pelvic Inflammatory Disease

1990